emat

Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples

 

 

► Subscribe to EMAT database

 

Sectors covered by our analysts

 

► Studies & indices published by Epsilon Research: Register to receive (free) publications updates

 

► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

 

Transaction Multiples for the Valuation of Private Companies

EMIS Group / Ascribe Group (now Emis Health)

No EMAT : 83413
Announced Date : 13/09/2013
Type : Exit ,Acquisition of Majority Stake
Deal Value : Yes
Acquirer : EMIS Group

Target : Ascribe Group (now Emis Health)
Country : United Kingdom
Sector of activity :
  • Specialized Software > Business Software > Software > Medical Software
Business Description :
Founded in 1984 by Stephen Critchlow, Ascrib e provides business intelligence, consultancy, and clinically focused IT solutions and services for healthcare customers. > Offers SaaS-based clinical...

Transaction multiples available
EV/
Sales
EV/
Gross Profit
EV/
EBITDA
EV/
EBIT
Eq/
PBT
P/E Price
to Book
Specific
multiple(s)
Historic
Current
Rating : **
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Medical Software » = 75
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
01/07/2010 Google (Alphabet) ITA Software United States ** 83380
26/08/2014 Craneware Kestros (now Craneware Health) Scotland ** 83278

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report